Additionally, Luo et al. reported that SLL-1A-16, a novel organoselenium compound, demonstrated anti-proliferative effects on NSCLC by inducing autophagy and inhibiting cell proliferation via the Akt/mTOR pathway (Luo X. et al., 2024). The gene discussed is MTOR; the disease is non-small cell lung carcinoma.